Chiếc, Cinthie , Demimoore, Chelitas, Ididtoomuchecstacynowimsadandmybackhurts, Chris Peterson, Chimenti, Cia Officer, Diarrhea, Comercial Para Empresa, Ciclodellacqua, Chris Warren, Charrito, China,, Deadly Gun, Covey, Deezer,, Fatih, Concentrate,, Denversbest, Christmasfreestyle, Coronaleugner, Collège;, Christmas Canceled , Eyde, Cris Melendez, Donks, Corrupt(Uk), Disco Ball,  Chitarra Classica, Coindash, Chilltechno, Darkcast , Cosmic Tuba, Crewchatspodcast, Chemical Plant, Daggaraina, Christophercousins

Albumdesign tik tok background DOWNLOAD

It's not what happened, but what didn't happen at the Stormy trial that tells the real story. In this episode, I cover the facts and testimonies from the ongoing witch-hunt trial against Trump.

The Real Story Behind The Stormy Trial (Ep, 2247)

In this episode, Rich and Pip discuss vaccine-induced immune thrombotic thrombocytopenia and heparin-induced thrombocytopenia. They critique a recent paper that has shown that VITT has been around before vaccines against Covid-19. Importantly, they discuss which patients should be tested for spontaneous VITT- and HIT-like syndromes, and discuss a recent case.

The paper is: Schönborn L. et al. Anti-PF4 immunothrombosis without proximate heparin or adenovirus vector vaccine exposure. Blood. 2023 Dec 28;142(26):2305-2314.

Don't Just Read the Abstract: VITT & HIT

The topics, stocks and shares mentions / discussed include:
Winning watchlist investing opportunities from the market sell-off,
Polar Capital Holdings / POLR
Visa / V
Rightmove / RMV
Moody's / MCO
Wood Group / WG.
Croda / CRDA
AstraZeneca / AZN
St James's Place / STJ
The Japanese Carry Trade,
Keras Resources / KRS
Mkango Resources Ltd / MKA
The Volatility Index VIX
Dividends
Risk Management
FTSE 100 / FTSE All-share / AIM All-share
Charity 
Sharescope / Sharepad www.sharescope.co.uk/landing_sharepad.jsp special discount offer code : TwinPetes
Phil Oakley’s blog investingstuff.substack.com/
Henry Viola-Heir’s blog theethicalentrepreneur.com/
Investors’ Chronicle www.investorschronicle.co.uk/product-ma…eferer=cta sponsor the TwinPetesInvesting Challenge
Harriman House books harriman.house/
Powder Monkey Brewing Co powdermonkeybrewing.com/collections/all-products 10% discount code : TWINPETES
CENTREPOINT Charity Appeal please make a donation on the TwinPetes Investing Charity Challenge 2024 www.justgiving.com/page/twinpeteschallenge24 Just Giving page
Trading
Investing & more

The Twin Petes Challenge 2024 / Charity fundraise is for the CENTREPOINT Charity. Have you enjoyed one or more of these podcasts. Yes . Then please make a donation , every pound will help.
www.justgiving.com/page/twinpeteschallenge24
Thank you.

The Twin Petes Investing podcasts will be linked to and written about on the Conkers3 website and also on available via your favourite podcast and social media platforms. Thank you for reading this article and listening to this podcast, we hope you enjoyed it. Please share this article with others that you know will find it of interest.
PLEASE SUBSCRIBE TO THE TWIN PETES INVESTING PLATFORM THAT YOU ARE LISTENING TO THIS PODCAST ON. THANK YOU.

#Winning #investing opportunities, Rightmove, Visa, Moody's #POLR #CRDA #AZN WG. #STJ #KRS #MKA $VIX

Nutty professor Dr Lou Sec certainly isn't a role model for AZ-employees. Yet a lot can be learnt from watching him misbehave.

Dr Lou Sec Theme Song

Pharmaceutical companies AstraZeneca and MSD are making considerable progress in treating cancers that are known for being hard to treat, such as bladder tumours, lung cancers and certain forms of breast cancer.

Radio ARA Programme du 2024-09-18

What's right: Pharma companies making progress in cancer treatment

Emma Wille chats with oncology team director Dana Gheorghe, PhD, about the resurgence of radiopharmaceutical therapies in oncology.

Other platforms (in addition to SoundCloud):​

Apple Podcasts -   https://podcasts.apple.com/us/podcast/pharma-intelligence-podcasts/id923189836​

Google Podcasts - https://podcasts.google.com/feed/aHR0cHM6Ly9mZWVkcy5zb3VuZGNsb3VkLmNvbS91c2Vycy9zb3VuZGNsb3VkOnVzZXJzOjEwNjU1NDkyOC9zb3VuZHMucnNz​

​TuneIn - https://tunein.com/podcasts/Business--Economics-Podcasts/Pharma-Intelligence-Podcasts-p1140128/​

September 2024 Datamonitor Healthcare Podcast: Radiopharmaceutical Usage is Heating Up

Hello, listeners! It is September twenty-seventh, twenty twenty-four, and you're tuned in to AI Tech News Today, where we keep you updated on the latest happenings in the world of artificial intelligence. Let's dive into today's news!

Runway launches one million dollar fund for filmmakers for AI-powered filmmaking. This initiative follows their groundbreaking deal with Lionsgate and aims to empower both established and emerging creators to explore artificial intelligence as a new storytelling tool. If you have a great idea for an AI-based film project, this could be your golden ticket!

How Google DeepMind's AlphaChip is transforming chip design. AlphaChip employs an innovative edge-based graph neural network to understand the relationships between chip components. This helps it generalize across different chip designs, potentially revolutionizing the way chips are created. A true game-changer for the semiconductor industry!

NotebookLM adds YouTube and audio support for richer insights. With new support for public YouTube URLs and audio files, users can now integrate a broader range of media into their notebooks. This update enhances research capabilities, empowering users to extract deeper insights from diverse sources. More tools for better knowledge acquisition—who could argue with that?

AstraZeneca and Immunai partner to boost cancer drug trials with artificial intelligence. This collaboration, valued at eighteen million dollars, seeks to improve the efficiency of clinical trials and accelerate the development of novel cancer therapies. With advancements in technology, the fight against cancer could soon get a much-needed boost.

Lastly, we have exciting AI tools making waves. Introducing ClipNow, which lets you easily convert your favorite YouTube videos into captivating TikToks or Shorts with just one click. If you're looking to create engaging content quickly, this tool might be just what you need!

That's all for today's roundup of AI news. Remember, technology is always evolving, and staying informed is key. Keep tuning in for more updates on the world of artificial intelligence, and as always, stay curious!

Runway Launches $1 Million Fund for AI Filmmakers, AlphaChip Transforms Semiconductor Design, and AstraZeneca Partners with Immunai for Innovative Cancer Trials

Stellen Sie sich vor, Sie bauen ein Haus. Bevor der erste Stein gelegt wird, braucht man einen detaillierten Bauplan. Und dann muss geklärt werden, ob eigentlich die Statik des Hauses oder der Feuerschutz gewährleistet sind. Mit der Zulassung eines Medikaments ist es ganz ähnlich. Jedes Arzneimittel muss zuvor in einer Studie darauf geprüft werden, ob es wirksam und verträglich ist. Und das braucht viel Vorbereitung. Bis eine neue Tablette in Krankenhäusern und Apotheken landet, ist es also ein langer Weg.  Wie Arzneimittelstudien im Einzelnen ablaufen und welche Bedeutung sie für Deutschland haben, darüber sprechen wir mit Dr. Doris Henn, Senior Director Clinical Research Biopharmaceuticals bei AstraZeneca und Dr. Rolf Hömke, Forschungssprecher beim vfa.

Medikamente auf dem Prüfstand - Wie plant man eine Arzneimittelstudie?

Did you know that according to research provided by the American Cancer Society, more than 2 million Americans will be diagnosed with cancer in 2025? Tune in for an inspiring discussion with Mohit Manrao, Senior Vice President of US Oncology at AstraZeneca, on the rising caner rates among younger adults. 
 
Moments with Marianne airs in the Southern California area on KMET 1490AM & 98.1 FM, an ABC Talk News Radio Affiliate!  https://www.kmet1490am.com

Mohit Manrao, Senior Vice President and Head of the US Oncology Business Unit at AstraZeneca, is responsible for leading commercial strategy and maximizing performance of their expansive oncology portfolio. Prior to assuming his current role in 2022, Mohit served as Vice President, Global Franchise Head Lung Cancer since 2020. Mohit joined AstraZeneca in 2012, holding various roles at the market, regional, and global-level across geographies, including Head of UK Oncology and Head of Daiichi Sankyo Alliance Europe. Mohit’s education includes Bachelor of Technology, Mechanical Engineering, Punjab Technical University and Masters of Business Administration, Indian School of Business. https://www.astrazeneca.com

For more show information visit:
www.MariannePestana.com

Rising Cancer Rates in Younger Adults with Mohit Manrao from AstraZeneca

Citeline places biopharma and medical device professionals, and those who focus on these industries, at the forefront of knowledge and insight, by providing the perfect combination of news and information together with penetrating insight and analysis. Citeline is a leader in the field of healthcare industry information.

News & Politics With Dan Bongino.
Website: www.Bongino.com
Watch us live weekdays at 11 AM ET at Rumble.com/bongino

Europe's best independent music station based in Luxembourg! English speaking.

In a single moment your life can change!  “Moments with Marianne” is a transformative hour that covers an endless array of topics with the ‘best of the best.’ Her guest are leaders in their fields, ranging from inspirational authors, top industry leaders, business and spiritual entrepreneurs.  Each guest is gifted, and a true visionary!  A recognized leader in her own work, and while teaching others to develop, refocus, and grow; Marianne will bring the best guest, and sometimes a special surprise.  Don’t miss this – you never know just which ‘moment’ will change your life forever.

Camar Media is a boutique marketing consultant focused on brand building, storytelling and copywriting – as well as sound design and music production.

A podcast about blood giving awesome, upcoming medics and scientists a platform to discuss new advances and express their opinions.

New tracks tagged #AstraZeneca